health Why Ozempic Fails for Some Patients: Stanford Uncovers a Genetic Resistance
New research from Stanford indicates that a specific genetic variant in the PAM enzyme causes biological resistance to GLP-1 drugs like Ozempic, impacting blood sugar control.
